EN
Enzolytics Inc.
ENZC · OTC
$0.00 +66.67% (+$0.00)
1M -16.67%
Market Cap $2.76M
P/E Ratio -
Div. Yield -
ROE 0.33%
Piotroski F-Score Weak
2/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
1 /100
Poor ROA 0.20%
ROIC 0.31%
Asset turnover 0.00x
Debt
53 /100
Moderate Net debt/EBITDA -2.97x
Current ratio 0.63x
Int. coverage -9.69x
Stability
29 /100
Unstable Profitable years 0
Beta 0.51x
EPS volatility 256.46%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ENZC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven Sharabura
Employees
1
Headquarters
Plano